Recognition of Primary Neuroendocrine Tumors - A Challenge Abstract #2067

Introduction: Neuro endocrine tumors of liver are rare.Most of the neuroendocrine tumors of the liver arise from gastrointestinal tract, especially from appendix.ileum and pancreas.Primary hepatic neuro endocrine tumors is a rare clinical entity, requiring strict exclusion of possible extra-hepatic primary sites for its diagnosis.Most challenging in diagnosis is diversity in presentation of primary symptoms.
Aim(s): To identify primary symptoms with which patients present in case of underlying neuro endocrine tumor.
Materials and methods: 35 diagnosed cases of neuro endocrine tumor were enrolled from different hospitals of Lahore.Diagnosis was done by histopathology of resectable tumors.Patients were enrolled from Sir Ganga Ram Hospital,Jinnah Hospital and Mayo hospital Lahore.Patients were interviewed about the primary symptoms.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Doctor Azka Athar
Authors: Athar A

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2114 Significance of Biochemical Testing in Pancreatic Neuroendocrine Tumors
Introduction: Pancreatic neuroendocrine tumors (PNETs) are rare tumors that are frequently diagnosed late in the course of the disease. Several biomarkers have been proposed in the literature for diagnosis in patients with these tumors.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Biomarkers
Presenting Author: Doctor Azka Athar
Authors: Athar A
#2138 Eterogeneity of Duodenal Neuroendocrine Tumors: A Multi-Centre Experience In Italy
Introduction: The optimal management of duodenal neuroendocrine neoplasms (dNENs) is unclear and endoscopic resection is increasingly performed instead of surgery.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: MD Roberta Elisa Rossi
#1679 Management of Neuroendocrine Tumors in the Netherlands
Introduction: To determine optimal management of patients with pancreatic neuroendocrine tumors (pNETs), more insight in the prognosis and treatment outcomes is needed.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: M.D. Cansu Genc
#2701 Assessing the Gaps in Experience and Knowledge of Australian Primary Health Care Professionals (GPs), in Treating and Caring for the Increasing Number of Australian Neuroendocrine Tumour (NET) Patients
Introduction: Conservatively,the incidence of NETs is 7 / 000' p.a, however,the prevalence of patients living with NETs is higher,40/000',making it the 2nd most common GI malignancy after colorectal cancer.Patients are living longer,however,with impaired quality of life.Management of debilitating symptoms such as diarrhoea,fatigue,anxiety,and flushing are complex and heterogenous.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Trials in Progress/Trials in Concept
Presenting Author: Simone Leyden
Authors: Leyden S, Cummins M, Wakelin K, ...
#97 The role of Ki-67 in the prognosis and management of neuroendocrine (NET) patients in a multdisciplinary cancer center
Introduction: The role of Ki-67 in NETs has become increasingly important, especially in light of the current trend in oncology to incorporate pathological molecular characteristics in determining treatment. In North America, Ki-67 is used inconsistently, as there exists some debate in the literature about its predictive value.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Simron Singh
Authors: Singh S, Rowsel C, Ingber N, Yang S, ...